Quantcast

Latest Clinical trial Stories

2014-04-30 08:31:35

ACRP Innovation Award is Latest for CRO Health Decisions DURHAM, N.C., April 30, 2014 /PRNewswire-iReach/ -- Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical devices companies, today announced that the Association of Clinical Research Professionals (ACRP) honored CEO Michael Rosenberg, MD, MPH, with its 2014 Innovation in Clinical Research Award at the ACRP Global Conference in San Antonio April 26. Photo -...

2014-04-29 16:30:53

Dr John Hong joins WCCT Global as Leading Private Investigator for Gastroenterology Clinical Trials COSTA MESA, Calif., April 29, 2014 /PRNewswire-iReach/ -- Today, WCCT Global announced that Dr. John Hong has joined the organization as the Head of GI Clinical Research. John Hong, MD, MBA brings many years of GI Clinical Care and Research experience to the role. He is a graduate of the University Of Miami School Of Medicine and completed his Internal Medicine Residency and...

2014-04-29 12:33:17

Theorem Selects iMedNet(TM) EDC as Their eClinical Solution of Choice for Medical Device & Diagnostics Research Initiatives MINNETONKA, Minn., April 29, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in eClinical technology systems, is pleased to welcome Theorem Clinical Research into the iMedNet Partner Program. Theorem, one of the industry's leading contract research organizations, provides comprehensive clinical research and development...

2014-04-29 09:52:38

New research looking at the success of clinical trials of stem cell therapy shows that trials appear to be more successful in studies where there are more discrepancies in the trial data. Researchers from Imperial College London conducted a meta-analysis of 49 randomised controlled trials of bone marrow stem cell therapy for heart disease. The study, published today in the British Medical Journal, identified and listed over 600 discrepancies within the trial reports. Discrepancies were...

2014-04-29 08:36:48

CSSi intervention led to successful closing of study enrollment two weeks ahead of schedule. GLEN BURNIE, Md., April 29, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently partnered with a major pharmaceutical company to prevent an anticipated reduction in the rate of patient enrollment for a dermatology study. So successful was CSSi's intervention through its patient enrollment and site performance program that it was...

2014-04-29 08:35:40

Binimetinib Continues to Advance in Clinical Development BOULDER, Colo., April 29, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the third quarter of its fiscal year ending June 30, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Revenue for the third quarter of fiscal 2014 was $7.8 million, compared to $10.0 million for the same period last year. Revenue decreased due to reduction in recognition of license and milestone payments from our...

2014-04-29 08:34:30

Tufts University will be a clinical site for international trial of CF102 with Orphan Drug Designation PETACH TIKVA, Israel, April 29, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT:CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has submitted a study protocol to the U.S. Food and Drug Administration for its Phase II clinical trial of CF102 for the treatment...

2014-04-28 23:03:29

Webinar Participants from the FDA and Covance Will Discuss the FDA Guidelines On Using Risk-based Monitoring and How to Apply the Guidance When Conducting Clinical Trials Horsham, PA (PRWEB) April 28, 2014 DIA and Covance will co-host the complimentary webinar, “Risk-Based Monitoring: Regulatory Expectation and Operational Application,” on May 15 from 11 a.m. to 12:30 p.m. Webinar participants from the Food and Drug Administration (FDA) and Covance will discuss the FDA guidelines on...

2014-04-28 16:31:03

Industry veteran brings additional oncology drug development experience BOULDER, Colo., April 28, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization, Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined the company's board of directors, effective April 25, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Dr....

2014-04-28 12:27:49

NEW YORK, April 28, 2014 /PRNewswire-USNewswire/ -- Founder Michael J. Fox; CEO Todd Sherer, PhD; and Co-Founder and Executive Vice Chairman Deborah W. Brooks of The Michael J. Fox Foundation for Parkinson's Research (MJFF) are featured on the cover of the inaugural issue of Clinical Researcher, the journal of the Association of Clinical Research Professionals. http://photos.prnewswire.com/prnvar/20140425/79262 The April 2014 cover story, authored by Sherer and other MJFF staff, is...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related